AI lifestyle coaching vs. standard advice for fatty liver
Part of Digestive system clinical trials.
This trial tests if an artificial intelligence program can help people with fatty liver disease lose weight and improve liver health better than standard lifestyle advice. You'll be randomly assigned to one of two groups and followed for several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your body mass index (BMI) is between 25 and 45
- Your weight has been stable (no big gain or loss) for the last 3 months
- You have a fatty liver diagnosis confirmed by a special ultrasound test (Fibroscan) showing more than 300 dB/m of fat
- Your liver stiffness score on Fibroscan is less than 8.5 kPa (meaning no severe scarring)
- You have WiFi at home and can follow the study instructions
- You have French national health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
This study tests how well primary care doctors can screen for advanced liver scarring in people with fatty liver from non-alcohol causes or from alcohol use. It may help find liver problems earlier so you can get the right follow-up.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
This study uses artificial intelligence to help doctors identify fatty liver disease from CT scans you may already be having. If eligible, you'll have some blood tests and possibly an ultrasound or MRI to confirm liver health, helping catch liver disease early.
This trial tests a digital lifestyle program (diet and activity coaching) to help people with HIV and fatty liver disease lose weight. It aims to see if the program can reduce body fat in the liver and improve overall health.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
Hear when a new Non Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.